• Pasithea Therapeutics Announces Participation in B. Riley Securities Mind, Muscle & Vision Summit GlobeNewswire Wed, 08 Jul 2026 11:02:00 GMT
• Pasithea management to meet investors at B. Riley health summit in Boston Stock Titan Wed, 08 Jul 2026 11:02:00 GMT
• Coastlands holds 3.84M shares in Pasithea Therapeutics (KTTA) — 11.48% disclosed Stock Titan Thu, 02 Jul 2026 00:51:07 GMT
• Pasithea Therapeutics Corp Warrant 2021-12.08.26 on Pasithea Therapeutics Financial Disclosures & SEC Filings TradingView Thu, 02 Jul 2026 00:34:10 GMT
• Pasithea extends dose escalation for MEK inhibitor PAS-004 Investing.com UK Tue, 30 Jun 2026 16:09:51 GMT
• pasithea therapeutics announced positive interim data from its phase 1 study targeting advanced cancer. Bitget Tue, 30 Jun 2026 12:14:37 GMT
• pasithea therapeutics announces updated data from pas-004 trial TipRanks Tue, 30 Jun 2026 11:52:39 GMT
• Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data Demonstrating Long-Term Safety and Tolerabilit... Yahoo Finance Tue, 30 Jun 2026 07:00:00 GMT
• Pasithea says PAS-004 stayed tolerable in cancer patients as dosing widens Stock Titan Tue, 30 Jun 2026 07:00:00 GMT
• Pasithea Therapeutics Corp. announced that its candidate drug Pas-4 demonstrated a favorable safety profile in clinical studies. Bitget Tue, 30 Jun 2026 03:06:04 GMT
• enterprise value to revenue forward of pasithea therapeutics corp. – nasdaq:ktta TradingView Mon, 29 Jun 2026 19:23:14 GMT
• Price to book forward of Pasithea Therapeutics Corp. – NASDAQ:KTTA TradingView Mon, 29 Jun 2026 06:38:56 GMT
• enterprise value to revenue forward of pasithea therapeutics corp. – boats:kttaw TradingView Fri, 26 Jun 2026 19:03:44 GMT
• price to sales forward of pasithea therapeutics corp. – boats:kttaw TradingView Fri, 26 Jun 2026 17:36:04 GMT
• pasithea therapeutics corp. actuals & estimates (nasdaq:ktta) TradingView Fri, 26 Jun 2026 16:13:02 GMT
• pasithea therapeutics corp. financial disclosures & sec filings TradingView Wed, 24 Jun 2026 04:44:16 GMT
• form 13g pasithea therapeutics corp. for: 23 june by investing.com Investing.com South Africa Wed, 24 Jun 2026 02:55:45 GMT
• Form 13G Pasithea Therapeutics Corp. For: 23 June By Investing.com Investing.com Nigeria Tue, 23 Jun 2026 22:21:56 GMT
• Stonepine Group reports 5.8% stake in Pasithea Therapeutics (KTTA) Stock Titan Tue, 23 Jun 2026 07:00:00 GMT
• pasithea therapeutics corp (kttaw) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 23 Jun 2026 07:00:00 GMT
• major investor quietly boosts stake in pasithea therapeutics TipRanks Tue, 23 Jun 2026 02:20:03 GMT
• coastlands capital lp acquires $53,000 of pasithea stock by investing.com Investing.com Nigeria Mon, 22 Jun 2026 14:59:01 GMT
• form 4 pasithea therapeutics corp for: 22 june by investing.com Investing.com UK Mon, 22 Jun 2026 14:44:00 GMT
• Coastlands Capital LP (KTTA) adds 100,000 Pasithea Therapeutics shares in open-market buy Stock Titan Mon, 22 Jun 2026 07:00:00 GMT
• pasithea therapeutics corp (ktta) financial health: profitability & balance sheet analysis TradingKey Thu, 18 Jun 2026 17:40:37 GMT
• pasithea therapeutics corp (ktta) valuation: pe, pb & fair value analysis TradingKey Thu, 18 Jun 2026 17:36:04 GMT
• pasithea therapeutics corp (ktta) institutional confidence TradingKey Thu, 18 Jun 2026 17:15:19 GMT
• pasithea therapeutics corp (ktta) earnings forecast: future eps & revenue growth estimates TradingKey Thu, 18 Jun 2026 17:11:47 GMT
• pasithea therapeutics corp (ktta) risk assessment: volatility, financial risk & investment risk TradingKey Thu, 18 Jun 2026 17:08:55 GMT
• pasithea therapeutics corp (ktta) revenue breakdown: business segments, regional revenue & profit contribution TradingKey Wed, 17 Jun 2026 21:52:05 GMT
• pasithea therapeutics corp (ktta) dividends & stock splits: historical payouts and event timeline TradingKey Wed, 17 Jun 2026 21:49:49 GMT
• pasithea therapeutics corp (ktta) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 21:30:17 GMT
• pasithea therapeutics corp (kttaw) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 18:54:39 GMT
• pasithea therapeutics corp (kttaw) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:48:02 GMT
• pasithea therapeutics corp (kttaw) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 18:47:27 GMT
• pasithea therapeutics corp (kttaw) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 18:47:13 GMT
• pasithea therapeutics corp (kttaw) shareholder structure: major shareholders & institutional holdings TradingKey Wed, 17 Jun 2026 18:43:44 GMT
• pasithea therapeutics corp (kttaw) institutional confidence TradingKey Wed, 17 Jun 2026 18:26:42 GMT
• pasithea therapeutics corp (kttaw) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 18:17:36 GMT
• analysts are bullish on top healthcare stocks: pasithea therapeutics corp (ktta), adaptive biotechnologies (adpt) The Globe and Mail Wed, 17 Jun 2026 15:52:00 GMT
• Pasithea Therapeutics Corp (KTTAW) Dividends & Stock Splits: Historical Payouts and Event Timeline TradingKey Wed, 17 Jun 2026 10:50:44 GMT
• pasithea therapeutics corp (ktta) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 07:00:00 GMT
• pasithea therapeutics announces amendments to pas-004 clinical study TipRanks Tue, 16 Jun 2026 16:30:48 GMT
• pasithea amends phase 1/1b trial protocol for pas-004 in nf1 Investing.com UK Tue, 16 Jun 2026 11:10:00 GMT
• Pasithea Therapeutics Announces Amendments to Clinical Study Protocol for Phase 1/1B NF1 Clinical Trial Yahoo! Finance Canada Tue, 16 Jun 2026 07:00:00 GMT
• Pasithea NF1 trial to track patients for 18 months, expand PAS-004 dosing Stock Titan Tue, 16 Jun 2026 07:00:00 GMT
• KTTA Reiterates by HC Wainwright & Co. -- Price Target Maintained at $3.00 GuruFocus Tue, 16 Jun 2026 07:00:00 GMT
• pasithea therapeutics corp (ktta) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• pasithea therapeutics corp (kttaw) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• pasithea therapeutics corp (kttaw) earnings forecast: future eps & revenue growth estimates TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• Pasithea's Strategic Gambit: Refining a Trial to Redefine NF1 Treatment BriefGlance Tue, 16 Jun 2026 03:27:22 GMT
• pasithea therapeutics announces exhibit at children’s tumor foundation 2026 nf conference GlobeNewswire Mon, 15 Jun 2026 07:00:00 GMT
• pasithea therapeutics to engage with nf1 community at 2026 children's tumor foundation conference following fda designations for p... Quiver Quantitative Mon, 15 Jun 2026 07:00:00 GMT
• pasithea therapeutics (ktta) could find a support soon, here's why you should buy the stock now MSN Sat, 13 Jun 2026 11:35:15 GMT
• pasithea therapeutics (ktta) could find a support soon, here's why you should buy the stock now MSN Fri, 12 Jun 2026 09:53:06 GMT
• pasithea therapeutics corp. (ktta) q1 2026 earnings: narrower-than-expected loss lifts shares - eps consistency score newsline.com Fri, 12 Jun 2026 01:48:23 GMT
• Pasithea Therapeutics (KTTA) Could Find a Support Soon, Here's Why You Should Buy the Stock Now Yahoo Finance Wed, 10 Jun 2026 07:00:00 GMT
• pasithea therapeutics (ktta) q1 2026 earnings: narrowed loss beats estimates as pre-revenue biotech focuses on pipeline - eps grow... newsline.com Tue, 09 Jun 2026 13:45:43 GMT
• KTTA Q1 2026 Earnings: Narrower-Than-Expected Loss Surprises as Operational Efficiency Improves dars.gov.et Sun, 07 Jun 2026 07:00:00 GMT
• pasithea therapeutics granted orphan drug designation for pas-004 by fda TipRanks Wed, 03 Jun 2026 07:06:35 GMT
• Miami Beach biotech lands FDA orphan drug designation for ALS treatment The Business Journals Wed, 03 Jun 2026 07:00:00 GMT
• pasithea therapeutics granted orphan drug designation for pas-004 by fda TipRanks Tue, 02 Jun 2026 20:37:30 GMT
• fda grants orphan drug status to pasithea als candidate pas-004 grafa.com Tue, 02 Jun 2026 14:42:20 GMT
• pasithea receives orphan drug status for als treatment candidate by investing.com Investing.com Canada Tue, 02 Jun 2026 11:18:52 GMT
• pasithea’s als drug designation: a strategic lifeline for patients & investors BriefGlance Tue, 02 Jun 2026 11:02:00 GMT
• Pasithea Therapeutics Announces Orphan Drug Designation by GlobeNewswire Tue, 02 Jun 2026 07:00:00 GMT
• FDA grants rare-disease status to Pasithea ALS drug PAS-004 Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• pasithea therapeutics (ktta) slips 3% as shares test key support near $0.64 - bollinger squeeze newsline.com Fri, 29 May 2026 07:00:00 GMT
• Pasithea Therapeutics (KTTA) Q1 2026 Earnings: Narrower-than-Expected Loss Drives Positive Market Reaction dars.gov.et Thu, 28 May 2026 07:00:00 GMT
• ktta q1 2026 earnings: narrower-than-expected loss drives positive stock reaction - consensus forecast report newsline.com Thu, 28 May 2026 07:00:00 GMT
• Is Pasithea Therapeutics (NASDAQ:KTTA) In A Good Position To Deliver On Growth Plans? simplywall.st Sun, 24 May 2026 07:00:00 GMT
• pasithea therapeutics corp. (ktta) q1 2026 earnings: significant eps beat despite zero revenue - high interest stocks Newser Sat, 23 May 2026 17:41:01 GMT
• ktta q1 2026 earnings: narrower-than-expected loss surprises markets as stock slips - analyst coverage count newsline.com Fri, 22 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) q1 2026 earnings beat: revenue $n/a, eps $-0.12 - earnings growth analysis newsline.com Thu, 21 May 2026 07:00:00 GMT
• h.c. wainwright maintains pasithea therapeutics(ktta.us) with buy rating, maintains target price $3 Moomoo Thu, 21 May 2026 07:00:00 GMT
• pasithea therapeutics: buy rating reiterated on pas-004 upside potential and strong cash runway; $3 price target maintained TipRanks Thu, 21 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) q1 2026 earnings: $-0.12 eps surges past $-0.46 estimates - earnings surprise report newsline.com Tue, 19 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) stalls at $0.78 — breakout or breakdown? 2026-05-18 - collar trade newsline.com Mon, 18 May 2026 07:00:00 GMT
• pasithea therapeutics corp. - common stock (nq: ktta The Chronicle-Journal Sun, 17 May 2026 13:34:08 GMT
• pasithea therapeutics corp reports results for the quarter ended march 31 - earnings summary TradingView Fri, 15 May 2026 21:41:23 GMT
• pasithea therapeutics corp. 1q 2026: net loss $(2.87m), eps $(0.12) — 10-q summary TradingView Fri, 15 May 2026 20:38:28 GMT
• pasithea therapeutics corp. reports earnings results for the first quarter ended march 31, 2026 marketscreener.com Fri, 15 May 2026 20:31:00 GMT
• pasithea therapeutics (ktta) q4 2025 disappoints — eps $-0.79 below $-0.18 views - earnings season outlook newsline.com Fri, 15 May 2026 07:00:00 GMT
• pasithea therapeutics corp expected to post a loss of 45 cents a share - earnings preview TradingView Fri, 15 May 2026 07:00:00 GMT
• pasithea therapeutics (nasdaq: ktta) ramps pas-004 r&d on $50m cash base Stock Titan Fri, 15 May 2026 07:00:00 GMT
• ameriprise (ktta) reports 1.35m-share, 5.4% stake in pasithea therapeutics Stock Titan Fri, 15 May 2026 07:00:00 GMT
• pasithea therapeutics stock draws retail buzz as early data shows potential in treating inflammatory diseases MSN Thu, 14 May 2026 00:42:35 GMT
• pasithea therapeutics corp expected to post a loss of 45 cents a share - earnings preview TradingView Mon, 11 May 2026 07:00:00 GMT
• ktta stock price, quote & chart | pasithea therapeutics corp (nasdaq:ktta) ChartMill Thu, 07 May 2026 07:00:00 GMT
• pasithea (nasdaq: ktta) grants director 152,783 options at $0.841 strike Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea (ktta) director receives 152,783 stock options at $0.841 Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) director receives 152,783 stock options grant Stock Titan Tue, 05 May 2026 07:00:00 GMT
• [form 4] pasithea therapeutics corp. insider trading activity Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics (nasdaq: ktta) grants director emer leahy 152,783 options Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) cfo receives 1.13m-share stock option grant Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics (ktta) ceo awarded 1.76m stock options at $0.841 Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics (nasdaq: ktta) names chief medical officer as reporting insider on form 3 Stock Titan Tue, 05 May 2026 07:00:00 GMT
• pasithea therapeutics appoints dr. kartik krishnan as chief medical officer to advance pas-004 mek inhibitor for nf1 and rare dise... Minichart Tue, 05 May 2026 07:00:00 GMT
• press release: pasithea therapeutics announces appointment of kartik krishnan, m.d., ph.d. as chief medical officer Moomoo Mon, 04 May 2026 11:01:00 GMT
• Pasithea Therapeutics Announces Appointment of Kartik Krishnan, M.D., Ph.D. as Chief Medical Officer GlobeNewswire Mon, 04 May 2026 07:00:00 GMT
• Pasithea Therapeutics Appoints Kartik Krishnan as Chief Medical Officer citybiz Mon, 04 May 2026 07:00:00 GMT
• pasithea names kartik krishnan as chief medical officer Investing.com Mon, 04 May 2026 07:00:00 GMT
• pasithea therapeutics appoints new cmo, updates equity incentives TipRanks Mon, 04 May 2026 07:00:00 GMT
• pasithea therapeutics names kartik krishnan as new chief medical officer to lead pas-004 clinical development. Pluang Mon, 04 May 2026 07:00:00 GMT
• new cmo and large option grants at pasithea therapeutics (nasdaq: ktta) Stock Titan Mon, 04 May 2026 07:00:00 GMT
• ktta pasithea therapeutics shares climb 21 percent despite reporting a far wider than expected q4 2025 per share loss. - borrow ra... newser.com Mon, 04 May 2026 00:42:21 GMT
• Is Pasithea Therapeutics (NASDAQ:KTTA) In A Good Position To Deliver On Growth Plans? Yahoo Finance Sun, 03 May 2026 07:00:00 GMT
• ktta pasithea therapeutics shares climb 21 percent despite reporting a far wider than expected q4 2025 per share loss. - earnings ... The Legal Advocate Sun, 03 May 2026 07:00:00 GMT
• ktta stock price, quote & chart | pasithea therapeutics corp (nasdaq:ktta) ChartMill Tue, 28 Apr 2026 07:00:00 GMT
• ktta pasithea therapeutics reports steep q4 2025 eps miss far below analyst estimates even as stock edges higher. - revenue growth... Newser Sat, 25 Apr 2026 04:17:54 GMT
• ktta pasithea therapeutics reports steep q4 2025 eps miss far below analyst estimates even as stock edges higher. - post-earnings ... newsline.com Fri, 24 Apr 2026 07:00:00 GMT
• funicular funds (ktta) reports 1.84m shares, 7.4% stake in pasithea (ktta) Stock Titan Wed, 22 Apr 2026 07:00:00 GMT
• h.c. wainwright maintains pasithea therapeutics(ktta.us) with buy rating, maintains target price $3 富途牛牛 Tue, 21 Apr 2026 08:21:39 GMT
• analysts offer insights on healthcare companies: oculis holding (ocs) and pasithea therapeutics corp (ktta) The Globe and Mail Tue, 21 Apr 2026 07:00:00 GMT
• ktta reiterated by hc wainwright & co. -- price target maintained at $3.00 GuruFocus Mon, 20 Apr 2026 23:48:45 GMT
• Miami company secures key FDA pediatric disease designation for drug The Business Journals Mon, 20 Apr 2026 07:00:00 GMT
• pasithea therapeutics announces grant of rare pediatric disease designation (rpdd) by fda to pas-004 for treatment of neurofibroma... Yahoo Finance Mon, 20 Apr 2026 07:00:00 GMT
• pasithea therapeutics (ktta) stock employment data (grinds lower) 2026-04-20 - quality factor The Legal Advocate Mon, 20 Apr 2026 07:00:00 GMT
• fda grants rare pediatric disease status to pasithea’s pas-004 Investing.com Mon, 20 Apr 2026 07:00:00 GMT
• fda pediatric disease tag could put a $205m voucher in play for pasithea Stock Titan Mon, 20 Apr 2026 07:00:00 GMT
• h.c. wainwright maintains pasithea therapeutics(ktta.us) with buy rating, maintains target price $3 Moomoo Mon, 20 Apr 2026 07:00:00 GMT
• pasithea therapeutics announces u.s. fda granted rpdd to pas-004 TipRanks Mon, 20 Apr 2026 07:00:00 GMT
• coastlands capital reveals ktta (nasdaq: ktta) stake in shares and pre-funded warrants Stock Titan Sat, 18 Apr 2026 02:08:58 GMT
• form 3 - initial statement of beneficial ownership of securities ADVFN Sat, 18 Apr 2026 01:45:12 GMT
• coastlands capital reveals ktta (nasdaq: ktta) stake in shares and pre-funded warrants Stock Titan Fri, 17 Apr 2026 07:00:00 GMT
• ktta stock price, quote & chart | pasithea therapeutics corp (nasdaq:ktta) ChartMill Fri, 17 Apr 2026 07:00:00 GMT
• can pasithea therapeutics corp grow without external funding - 2026 momentum check & verified short-term plans baoquankhu1.vn Mon, 13 Apr 2026 15:23:11 GMT
• loss report: what is the next catalyst for pasithea therapeutics corp equity warrant - portfolio gains summary & risk adjusted buy... baoquankhu1.vn Sat, 11 Apr 2026 17:23:16 GMT
• pasithea therapeutics corp. (ktta) stock price | live quotes & charts | nasdaq StocksToTrade Sat, 11 Apr 2026 00:42:00 GMT
• ktta stock price, quote & chart | pasithea therapeutics corp (nasdaq:ktta) ChartMill Fri, 10 Apr 2026 07:00:00 GMT
• is pasithea therapeutics (ktta) stock good for passive investors | price at $0.76, down 0.52% - index put call The Legal Advocate Thu, 09 Apr 2026 07:00:00 GMT
Pasithea Therapeutics(NASDAQ:KTTA) 
Pasithea Therapeutics Corp., a biotechnology company, engages in research and discovery of treatments for psychiatric and neurological disorders. The company also intends to operate anti-depression clinics and provide business support services using trained pharmacists to administer intravenous infu...
Share this website to your friends